Biotech

All Articles

ReNeuron leaving behind purpose exchange after missing fundraising goal

.ReNeuron has actually participated in the long listing of biotechs to leave Greater london's goal s...

MBX files for IPO to take challenger to Ascendis into stage 3

.MBX Biosciences has added to the recent outbreak of IPO filings. The biotech, which submitted its o...

FDA increases probing right into Lykos' MDMA trials: WSJ

.For Lykos Rehabs and the provider's would-be MDMA-assisted therapy for trauma (POST-TRAUMATIC STRES...

Gene publisher Tome laying off 131 workers

.Just times after genetics publisher Volume Biosciences revealed unrevealed operational cuts, a more...

Repare lays off 25% of personnel as biotech stops preclinical R&ampD

.Repare Therapeutics is actually giving up a fourth of its own workforce as the oncology biotech dow...

J &amp J files for FDA approval of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually taken one more step towards understanding a gain on its own $6.5 ...

Gain's phase 1 win paves means to confirm Parkinson's medicine's worth

.Increase Rehabs has actually specified its direct confirming the performance of its own Parkinson's...

Actinogen files brand new phase 2 data to salvage clinical depression medicine

.Actinogen Medical's hopes-- as well as sell cost-- have rebounded somewhat coming from previously t...

Pfizer and Crown jewel add Quotient to multibillion-dollar equation

.Main Pioneering and Pfizer have actually incorporated Quotient right into their 10-program partners...

Bayer pens $547M treaty to push limits of noncoding RNA

.Bayer execs were interested to stress to Fierce this summer months that the German pharma titan's c...